Home / Attorneys / Josh Littlejohn Josh Littlejohn Member Securities Class Actions, Whistleblower Claims Experience 843.216.9447 Contact Josh Download V-Card With a broad base of experience in complex litigation—including securities fraud, corporate governance, whistleblower cases under Dodd-Frank and the False Claims Act, and catastrophic injury and death cases—Josh Littlejohn is a key member of Motley Rice’s securities and corporate governance teams, with experience in cases involving healthcare, technology, and finance. With a broad base of experience in complex litigation—including securities fraud, corporate governance, whistleblower cases under Dodd-Frank and the False Claims Act, and catastrophic injury and death cases—Josh Littlejohn is a key member of Motley Rice’s securities and corporate governance teams, with experience in cases involving healthcare, technology, and finance. Josh represents public pension funds, unions and other institutional investors in both federal and state courts. He also represents people with catastrophic personal injuries and corporate whistleblowers. Josh works directly with clients and has been involved in all aspects of the litigation process, including case evaluation, fact and expert discovery, resolution and trial.Throughout his career Josh has been involved in numerous complex securities matters including serving as lead or co-lead counsel in cases involving Wells Fargo & Company; Alexion Pharmaceuticals; Seagate Technologies; Globe Life; Shoals Technologies Group; Amazon; Wells Fargo & Company; 3D Systems Corporation; St. Jude Medical, Inc.; Omnicare; and numerous others. Along with other Motley Rice lawyers, Josh was South Carolina liaison counsel in a securities fraud class action filed in federal court in the District of South Carolina that settled in 2020 filed by investors against SCANA Corporation over its failed nuclear reactor project. Josh regularly reviews and analyzes new securities fraud, corporate governance, and SEC whistleblower matters on behalf of our clients and the firm. In addition to securities and personal injury matters, Josh evaluates and litigates violations of the federal False Claims Act and Anti-kickback Statute on behalf of corporate whistleblowers.Aside from various securities and whistleblower matters, Josh was a part of the Motley Rice negotiating team that helped secure a resolution with a major U.S. auto manufacturer on behalf of Takata airbag victims. Early in his career, Josh worked on discovery in mass tort litigation against large drug manufacturers. Connect With Josh or call 843.216.9447 Areas of Focus Securities Class Actions Whistleblower Claims Attorney Credentials Education J.D., Charleston School of Law, 2007 B.A., University of North Carolina at Asheville, 1999 State Licensed In South Carolina Admitted to Practice Before U.S. Court of Appeals for the Third and Fourth Circuits U.S. District Court for the District of Colorado and the District of South Carolina Associations American Bar Association South Carolina Association for Justice Josh's Awards, Accolades & Recognitions These honors recognize the work Josh has done for clients, community and the legal profession. No aspect of this advertisement has been approved by the Supreme Court of New Jersey. Super Lawyers® 2013–2017 South Carolina Super Lawyers Rising Stars listSecurities litigation; Class action/mass torts; General litigation Lawdragon 2019 Lawdragon 500 Plaintiff Financial Lawyers
Admitted to Practice Before U.S. Court of Appeals for the Third and Fourth Circuits U.S. District Court for the District of Colorado and the District of South Carolina
Alexion Securities Class Action Lawsuit - Settlement Securities Class Actions Motley Rice, as co-lead counsel, has negotiated a $125 million settlement to resolve securities class action claims brought on behalf of certain investors in Alexion Pharmaceuticals, Inc. The action, which was commenced in late 2016 in...
Corporate Takeover Litigation Securities Class Actions When directors and officers of a public company decide to undertake a corporate transaction such as a merger, acquisition or leveraged buyout, we work with company shareholders to help maximize share value and to avoid conflicts of...
Shareholder Derivative Lawsuit Securities Class Actions Antitrust Through shareholder derivative actions, we work with company investors to restore value lost to the company due to willful mismanagement, insider self-dealing or other acts of malfeasance.
Securities Fraud Securities Class Actions Antitrust Representing domestic and foreign institutional investors—including union, pension, and hedge funds—in recovering shareholder losses incurred due to corporate fraud.
Anti-Kickback Regulation: Omnicare, Inc. Securities Class Actions Manville Personal Injury Trust filed a shareholder derivative complaint against Omnicare, Inc., in 2010 for participating in illegal kickback schemes, necessitating new corporate governance measures.
Clinical Trial Complications: Pharmacia Corp Securities Class Actions A $164 million settlement was reached with Pharmacia Corp. et al in this securities fraud case regarding alleged misleading statements concerning the safety profile of anti-inflammatory drug, Celebrex.